Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Jinxiang YeDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0000-0002-5538-1301
Lifang QiDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0009-0005-1015-0058
Shuang DengDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.
Dandan WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0009-0004-7740-1491
Hengjiang CongDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0000-0002-9225-0095
Xiaotian QiDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0000-0001-5420-5958
Qianghui ZhouDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0000-0002-8125-0380
Hong-Gang ChengDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Engineering Research Center of Organosilicon Compounds and Materials (Ministry of Education), Hubei Key Lab on Organic and Polymeric OptoElectronic Materials, College of Chemistry and Molecular Sciences, The Institute for Advanced Studies, and TaiKang Center for Life and Medical Sciences, Wuhan University, 430072 Wuhan, China.ORCID 0000-0001-9585-9093
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Cross-electrophile coupling (XEC) is a powerful strategy for forming C-C bonds in synthetic organic chemistry. While XEC reactions between two electrophiles are well established, those involving three distinct electrophiles have remained underdeveloped. Herein, we report an intriguing formal triple XEC enabled by palladium/norbornene cooperative catalysis. Readily available aryl iodides, alkyl/aryl bromides, and propargyl esters are used as the distinct electrophilic coupling partners, leading to the synthesis of a diverse array of tetrasubstituted allenes. In particular, the challenging asymmetric formal triple XEC has also been realized through palladium/chiral norbornene cooperative catalysis, which uses the sterically hindered 2,6-disubstituted aryl bromides as the arylating reagents to prepare tetrasubstituted allenes bearing an axially chiral biaryl unit. Density functional theory calculations reveal that the selection of propargyl esters as electrophilic terminating reagents is key to the success of this reaction because it enables a thermodynamically favored pathway for reaction termination involving alkyne insertion followed by β-O elimination.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Triple cross-electrophile coupling enabled by palladium/norbornene cooperative catalysis. · full record | OpenQuestion